
1. nat med. 2014 mar;20(3):307-12. doi: 10.1038/nm.3461. epub 2014 feb 9.

persistence activation malaria hypnozoites long-term primary hepatocyte
cultures.

dembélé l(1), franetich jf(1), lorthiois a(2), gego a(2), zeeman am(3), kocken
ch(3), le grand r(4), dereuddre-bosquet n(4), van gemert gj(5), sauerwein r(5),
vaillant jc(6), hannoun l(6), fuchter mj(7), diagana tt(8), malmquist na(9),
scherf a(9), snounou g(2), mazier d(10).

author information: 
(1)1] sorbonne universités, université pierre et marie curie paris 6, umr s945,
paris, france. [2] institut national de la santé et de la recherche médicale,
u945, paris, france. [3].
(2)1] sorbonne universités, université pierre et marie curie paris 6, umr s945,
paris, france. [2] institut national de la santé et de la recherche médicale,
u945, paris, france.
(3)department parasitology, biomedical primate research centre, rijswijk, 
netherlands.
(4)1] division immuno-virology, institute emerging diseases innovative 
therapies, commissariat à l'energie atomique et aux energies alternatives,
fontenay-aux-roses, france. [2] université paris-sud xi, umre01, orsay, france.
(5)department medical microbiology, radboud university nijmegen medical
centre, nijmegen, netherlands.
(6)service de chirurgie digestive, hépato-bilio-pancréatique et transplantation
hépatique, hôpital pitié-salpêtrière, paris, france.
(7)department chemistry, imperial college london, south kensington campus,
london, uk.
(8)novartis institute tropical diseases, singapore.
(9)1] unité de biologie des interactions hôte-parasite, institut pasteur, paris, 
france. [2] centre national de la recherche scientifique, unité de recherche
associée 2581, paris, france.
(10)1] sorbonne universités, université pierre et marie curie paris 6, umr s945, 
paris, france. [2] institut national de la santé et de la recherche médicale,
u945, paris, france. [3] assistance publique-hôpitaux de paris, groupe
hospitalier pitié-salpêtrière, service parasitologie-mycologie, paris, france.

comment in
    nat med. 2014 mar;20(3):237-9.

malaria relapses, resulting activation quiescent hepatic hypnozoites 
of plasmodium vivax plasmodium ovale, hinder global efforts control and
eliminate malaria. primaquine, drug capable eliminating
hypnozoites, unsuitable mass administration, alternative drug needed
urgently. currently, analyses hypnozoites, including screening compounds
that would eliminate them, made using common macaque models,
principally macaca rhesus macaca fascicularis, experimentally infected with
the relapsing plasmodium cynomolgi. here, present protocol long-term 
vitro cultivation p. cynomolgi-infected m. fascicularis primary hepatocytes
during hypnozoites persist activate resume normal development. 
proof-of-concept experiment, obtained evidence exposure inhibitor
of histone modification enzymes implicated epigenetic control gene
expression induces accelerated rate hypnozoite activation. protocol
presented may enable investigations hypnozoite biology search 
for compounds kill hypnozoites disrupt quiescence.

doi: 10.1038/nm.3461 
pmid: 24509527  [indexed medline]

